Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study
Clinical trial NCT00462423 · COMPLETED
Trial details
- NCT number
- NCT00462423
- Sponsor
- Lynn E. Spitler, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2011-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.